Abridge Expands AI Clinical Decision Support to All Clinicians at Partner Health Systems

The health systems using Abridge include Kaiser Permanente, Sutter Health, UNC Health, CHRISTUS Health, Duke Health and UPMC. Collectively, the 300-plus organizations serve more than 250 million patients, according to Abridge.

Abridge is expanding its AI-powered clinical decision support (CDS) solution to every clinician at its partner health systems, extending the company’s role from AI documentation to broader clinical workflow support.

More than 300 enterprise health systems have adopted Abridge’s CDS solution since its April expansion, with monthly active users now exceeding half of eligible Abridge clinicians, the company said. Queries per clinician have also tripled over the past two months.

The health systems using Abridge include Kaiser Permanente, Sutter Health, UNC Health, CHRISTUS Health, Duke Health and UPMC. Collectively, the 300-plus organizations serve more than 250 million patients, according to Abridge.

The company said health systems can deploy the clinical intelligence agent through the same enterprise-approved infrastructure used for its ambient documentation tools, including existing security, governance and electronic health record integrations.

For clinicians already using Abridge as an AI scribe, the decision support agent is incorporated into the existing workflow. Other clinicians at participating organizations can access the AI assistant through mobile and desktop interfaces.

Abridge expanded its CDS capabilities in April through a partnership with Wolters Kluwer’s UpToDate, integrating context-aware clinical evidence into its ambient documentation workflow. The company has also established content integrations with the New England Journal of Medicine, JAMA Network, the American Diabetes Association, the American Academy of Family Physicians, Neurology and the Journal of Clinical Oncology.

At Duke Health, clinicians have used the solution to identify relevant guidance for complex cases, including a rare neurological presentation and an unusual facial rash. About 2,000 Duke clinicians currently use Abridge, according to Eric Poon, MD, chief health information officer at Duke Health.

UPMC has rolled out Abridge’s CDS solution enterprise-wide. Robert Bart, MD, chief medical information officer at UPMC Health Services Division, said more than 60% of the health system’s Abridge users adopted the feature largely through self-discovery without additional training.

Abridge is also positioning the solution as an enterprise-governed alternative to unsanctioned “shadow AI,” allowing clinicians to access patient-specific AI support within approved workflows.

The company has been expanding beyond ambient documentation, adding capabilities across pre-visit preparation, clinical documentation, referral workflows and evidence-based clinical queries. Abridge also recently introduced Care Signals, an agentic AI capability developed with Kaiser Permanente to capture additional clinical information from patient encounters.

As the platform expands, healthcare leaders continue to emphasize that AI-generated guidance should support rather than replace clinical judgment. Poon said AI can broaden access to expertise, while clinicians remain responsible for critical thinking and final decisions.

Stay tuned for more such updates on Digital Health News